Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Dickkopf-1 overexpression in vitro nominates candidate blood biomarkers relating to Alzheimer's Disease pathology

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Causes of Death in People with Dementia from 2002 to 2015: A Nationwide Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Comparing a Single Clinician Versus a Multidisciplinary Consensus Conference Approach for Dementia Diagnostics

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care

    Research output: Contribution to journalReviewResearchpeer-review

  4. Is the Frontal Lobe the Primary Target of SARS-CoV-2?

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. HIV infection is associated with type 2 diabetes mellitus

    Research output: Contribution to journalLetterResearchpeer-review

  2. Abnormal brain cholesterol homeostasis in Alzheimer’s disease—a targeted metabolomic and transcriptomic study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Antibody-dependent neutralizing capacity of the SARS-CoV-2 vaccine BNT162b2 with and without previous COVID-19 priming

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Liu Shi
  • Laura M Winchester
  • Benjamine Y Liu
  • Richard Killick
  • Elena M Ribe
  • Sarah Westwood
  • Alison L Baird
  • Noel J Buckley
  • Shengjun Hong
  • Valerija Dobricic
  • Fabian Kilpert
  • Andre Franke
  • Steven Kiddle
  • Martina Sattlecker
  • Richard Dobson
  • Antonio Cuadrado
  • Abdul Hye
  • Nicholas J Ashton
  • Angharad R Morgan
  • Isabelle Bos
  • Stephanie J B Vos
  • Mara Ten Kate
  • Philip Scheltens
  • Rik Vandenberghe
  • Silvy Gabel
  • Karen Meersmans
  • Sebastiaan Engelborghs
  • Ellen E De Roeck
  • Kristel Sleegers
  • Giovanni B Frisoni
  • Olivier Blin
  • Jill C Richardson
  • Régis Bordet
  • José L Molinuevo
  • Lorena Rami
  • Anders Wallin
  • Petronella Kettunen
  • Magda Tsolaki
  • Frans Verhey
  • Alberto Lleó
  • Daniel Alcolea
  • Julius Popp
  • Gwendoline Peyratout
  • Pablo Martinez-Lage
  • Mikel Tainta
  • Peter Johannsen
  • Charlotte E Teunissen
  • Yvonne Freund-Levi
  • Lutz Frölich
  • Cristina Legido-Quigley
  • Frederik Barkhof
  • Kaj Blennow
  • Katrine Laura Rasmussen
  • Børge Grønne Nordestgaard
  • Ruth Frikke-Schmidt
  • Sune Fallgaard Nielsen
  • Hilkka Soininen
  • Bruno Vellas
  • Iwona Kloszewska
  • Patrizia Mecocci
  • Henrik Zetterberg
  • B Paul Morgan
  • Johannes Streffer
  • Pieter Jelle Visser
  • Lars Bertram
  • Alejo J Nevado-Holgado
  • Simon Lovestone
View graph of relations

Background: Previous studies suggest that Dickkopf-1 (DKK1), an inhibitor of Wnt signaling, plays a role in amyloid-induced toxicity and hence Alzheimer's disease (AD). However, the effect of DKK1 expression on protein expression, and whether such proteins are altered in disease, is unknown. Objective: We aim to test whether DKK1 induced protein signature obtained in vitro were associated with markers of AD pathology as used in the amyloid/tau/neurodegeneration (ATN) framework as well as with clinical outcomes. Methods: We first overexpressed DKK1 in HEK293A cells and quantified 1,128 proteins in cell lysates using aptamer capture arrays (SomaScan) to obtain a protein signature induced by DKK1. We then used the same assay to measure the DKK1-signature proteins in human plasma in two large cohorts, EMIF (n = 785) and ANM (n = 677). Results: We identified a 100-protein signature induced by DKK1 in vitro. Subsets of proteins, along with age and apolipoprotein E ϵ4 genotype distinguished amyloid pathology (A + T-N-, A+T+N-, A+T-N+, and A+T+N+) from no AD pathology (A-T-N-) with an area under the curve of 0.72, 0.81, 0.88, and 0.85, respectively. Furthermore, we found that some signature proteins (e.g., Complement C3 and albumin) were associated with cognitive score and AD diagnosis in both cohorts. Conclusions: Our results add further evidence for a role of DKK regulation of Wnt signaling in AD and suggest that DKK1 induced signature proteins obtained in vitro could reflect theATNframework as well as predict disease severity and progression in vivo.

Original languageEnglish
JournalJournal of Alzheimer's Disease
Issue number3
Pages (from-to)1353-1368
Number of pages16
Publication statusPublished - 2020

    Research areas

  • ATN framework, Dickkopf-1, replication, SomaScan, Wnt signaling

ID: 61261692